Phospholipid ether-enriched lipid rafts (PLE-enriched lipid rafts)

Phospholipid ether-enriched lipid rafts are specialized membrane microdomains that are significantly more abundant on the surface of malignant cells compared to healthy cells (Source: Weichert et al., 2014, Science Translational Medicine). These domains are characterized by a high concentration of ether-linked phospholipids, which play a critical role in organizing signaling proteins that drive cancer cell proliferation and survival, such as the PI3K/Akt pathway (Source: Li et al., 2006, Cancer Research). Because cancer cells lack the necessary enzymes, such as alkylglycerol monooxygenase, to efficiently metabolize certain ether lipid analogs, these rafts serve as a unique portal for the selective uptake and retention of therapeutic agents like alkylphosphocholines (APCs) (Source: Cellectar Biosciences). This differential lipid composition allows for the targeted delivery of cytotoxic payloads, including radioisotopes like I-131 and fluorescent markers, specifically to tumor cells while sparing normal tissues. Consequently, these rafts are a primary target for novel diagnostic and therapeutic strategies in oncology, particularly for hard-to-treat cancers like glioblastoma and multiple myeloma (Source: PubMed PMID 24019511).

Other names

Ether lipid-enriched microdomainsCancer-specific lipid raftsAlkylphosphocholine-binding lipid domainsPLE-LR

Selective accumulation and prolonged retention in cancer cells due to the high density of ether lipids in malignant lipid rafts; these domains serve as entry points for alkylphosphocholine analogs which then disrupt pro-survival signaling (e.g., Akt pathway) or deliver localized radiotherapy via radioisotopes.